Hepatitis C Prevention Opportunities Among People Who Inject Drugs Webinar
April 28, 2015 | 1:00 PM - 2:00 PM EDT
According to the Centers for Disease Control and Prevention (CDC), reported cases of acute hepatitis C (HCV) have increased by 75% from 2010 to 2012 indicating an urgent need for HCV prevention information, tools, and strategies. This increase is especially pronounced among young people who inject drugs (PWID) after a history of oral opioid prescription drug abuse.
The HHS Office of HIV/AIDS and Infectious Disease Policy hosted a webinar that highlights opportunities for HCV prevention among PWID. Webinar participants will learn about current HCV trends, new tools and prevention messages, and highlights of HCV prevention research among PWID, all of which can help stop the spread of viral hepatitis associated with drug use as prioritized by the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis.
Related Materials and Resources
HHS Office of HIV/AIDS and Infectious Disease Policy
Tags: CoC ESG HOPWA